Getinge welcomes visitors to attend the inauguration of a new Experience Center in Frankfurt
Getinge’s new Experience Center in Frankfurt, Germany is part of the company’s continuous strive to interact with, and support, customers and partners. It will showcase Getinge’s broad portfolio of innovative and sustainable health care and life science solutions.
The inauguration takes place on May 9, 2022, at 17:00 CEST and will be hosted by Mattias Perjos, President & CEO, Carsten Blecker, Chief Commercial Officer, and Josef Hinterberger, President DACH & BeNeLux at Getinge. Getinge is also happy to announce the participation of distinguished guests such as the Swedish Ambassador to Germany Mr. Per Thöresson, Dr. Anke Diehl, CTO and Head of the Digital Transformation Unit at University hospital Essen and Prof. Dr. Claudia Bozzaro, Head of the Medical Ethics Unit at the Institute for Experimental Medicine at Christian-Albrechts-Universität, Kiel.
The virtual inauguration program will cover exciting presentations of the future and digitalization of the health care system, sustainability in the medtech business and a virtual tour of the center. To join the event, register here.
The new Getinge Experience Center is located at Gateway Gardens in Frankfurt, Germany, close to the international airport, and will be open for visitors on weekdays. The center includes both product exhibition areas, training facilities and offices.
Read more about Getinge’s Experience Centers.
For more information:
Anna Appelqvist, Vice President Corporate Communications
Phone: +46 (0)10 335 5906
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.